These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37953795)

  • 1. INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusion.
    Weinberg E; Rahematpura S; Gonzalez SA; Izzy MJ; Simonetto DA; Frederick RT; Rubin RA; Ikahihifo-Bender J; Harte M; Kim-Lee G; Witkiewicz S; Tobin W; Jamil K; Fricker Z; Reddy KR
    Contemp Clin Trials Commun; 2023 Dec; 36():101211. PubMed ID: 37953795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population.
    Reddy KR; Weinberg EM; Gonzalez SA; Izzy MJ; Simonetto DA; Frederick RT; Rubin RA; Fricker Z; Ikahihifo-Bender J; Harte M; Garcia S; Campbell K; Olofson A; Razavi RF; James JM; Patel H; Kim-Lee G; Witkiewicz S; Tobin W; Jamil K
    Liver Transpl; 2024 Oct; 30(10):1026-1038. PubMed ID: 38771635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
    Flamm SL; Wong F; Ahn J; Kamath PS
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Terlipressin Infusion in Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI): A Retrospective Observational Study.
    Gowda M; Dilipbhai DM; Jalihal U; Kumar MP; Gowda S B; Jain A; Ganjoo N
    Cureus; 2024 Aug; 16(8):e66581. PubMed ID: 39252705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI).
    Kulkarni AV; Lee J; Reddy KR
    Expert Rev Gastroenterol Hepatol; 2023; 17(11):1067-1079. PubMed ID: 37856367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of terlipressin for hepatorenal syndrome: the United States hospital perspective.
    Carter JA; Huang X; Jamil K; Corman S; Ektare V; Niewoehner J
    J Med Econ; 2023; 26(1):1342-1348. PubMed ID: 37729445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoconstrictor Therapy for Acute Kidney Injury Hepatorenal Syndrome: A Meta-Analysis of Randomized Studies.
    Singal AK; Palmer G; Melick L; Abdallah M; Kwo P
    Gastro Hep Adv; 2023; 2(4):455-464. PubMed ID: 39132033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
    Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terlipressin vs Midodrine Plus Octreotide for Hepatorenal Syndrome-Acute Kidney Injury: A Propensity Score-Matched Comparison.
    Gonzalez SA; Chirikov VV; Wang WJ; Huang X; Jamil K; Simonetto DA
    Clin Transl Gastroenterol; 2023 Dec; 14(12):e00627. PubMed ID: 37622521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study.
    Kulkarni AV; Ravikumar ST; Tevethia H; Premkumar M; Kumar K; Sharma M; Gupta R; Rao PN; Reddy DN
    Sci Rep; 2022 Apr; 12(1):5503. PubMed ID: 35365736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.
    Arora V; Maiwall R; Rajan V; Jindal A; Muralikrishna Shasthry S; Kumar G; Jain P; Sarin SK
    Hepatology; 2020 Feb; 71(2):600-610. PubMed ID: 30076614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatorenal Syndrome With Acute Kidney Injury: Diagnosis and Medical Management.
    Erstad BL
    Ann Pharmacother; 2024 Feb; 58(2):156-164. PubMed ID: 37271967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study).
    Jindal A; Singh H; Kumar G; Arora V; Sharma MK; Maiwall R; Rajan V; Tewathia HV; Vasishtha C; Sarin SK
    Dig Dis Sci; 2024 Jun; 69(6):2204-2214. PubMed ID: 38637454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravenous terlipressin infusion versus bolus in patients with acute-on-chronic liver failure-acute kidney injury - an open label RCT.
    Gupta T; Goel A; Ranga N; Goyal SK
    Clin Exp Hepatol; 2023 Dec; 9(4):351-358. PubMed ID: 38774204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-stage liver disease: Management of hepatorenal syndrome.
    Mauro E; Garcia-Olveira L; Gadano A
    Liver Int; 2021 Jun; 41 Suppl 1():119-127. PubMed ID: 34155791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward.
    Belcher JM; Parada XV; Simonetto DA; Juncos LA; Karakala N; Wadei HM; Sharma P; Regner KR; Nadim MK; Garcia-Tsao G; Velez JCQ; Parikh SM; Chung RT; Allegretti AS;
    Am J Kidney Dis; 2022 May; 79(5):737-745. PubMed ID: 34606933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Pharmacologic Therapies for Hepatorenal Syndrome-Acute Kidney Injury.
    Duong N; Kakadiya P; Bajaj JS
    Clin Gastroenterol Hepatol; 2023 Sep; 21(10S):S27-S34. PubMed ID: 37625864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome.
    Piano S; Gambino C; Vettore E; Calvino V; Tonon M; Boccagni P; Gringeri E; Germani G; Burra P; Cillo U; Angeli P
    Hepatology; 2021 May; 73(5):1909-1919. PubMed ID: 32870499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.
    Flamm SL; Brown K; Wadei HM; Brown RS; Kugelmas M; Samaniego-Picota M; Burra P; Poordad F; Saab S
    Liver Transpl; 2021 Aug; 27(8):1191-1202. PubMed ID: 33848394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Treatment of Hepatorenal Syndrome.
    Cavallin M; Fasolato S; Marenco S; Piano S; Tonon M; Angeli P
    Dig Dis; 2015; 33(4):548-54. PubMed ID: 26159272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.